Salud financiera de hoja de balance de Shanghai Shyndec Pharmaceutical
Salud financiera controles de criterios 6/6
Shanghai Shyndec Pharmaceutical has a total shareholder equity of CN¥15.2B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.1%. Its total assets and total liabilities are CN¥20.1B and CN¥4.9B respectively. Shanghai Shyndec Pharmaceutical's EBIT is CN¥1.5B making its interest coverage ratio -12.5. It has cash and short-term investments of CN¥5.6B.
Información clave
7.1%
Ratio deuda-patrimonio
CN¥1.08b
Deuda
| Ratio de cobertura de intereses | -12.5x |
| Efectivo | CN¥5.64b |
| Patrimonio | CN¥15.19b |
| Total pasivo | CN¥4.87b |
| Activos totales | CN¥20.07b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 600420's short term assets (CN¥11.6B) exceed its short term liabilities (CN¥4.6B).
Pasivo a largo plazo: 600420's short term assets (CN¥11.6B) exceed its long term liabilities (CN¥254.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 600420 has more cash than its total debt.
Reducción de la deuda: 600420's debt to equity ratio has reduced from 46.9% to 7.1% over the past 5 years.
Cobertura de la deuda: 600420's debt is well covered by operating cash flow (212.6%).
Cobertura de intereses: 600420 earns more interest than it pays, so coverage of interest payments is not a concern.